Is ONCO or ONCY more undervalued in 2026?

CirclFi compares Onconetix, Inc. (ONCO) and Oncolytics Biotech Inc. (ONCY) using 13 institutional-grade valuation models. ONCO has a Quality of Company score of 4.5/10 while ONCY scores 3.4/10.

Which is a better buy — ONCO or ONCY?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ONCO and ONCY valuations compare?

ONCO at $1.20 and ONCY at $1.04 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ONCO vs ONCY Valuation Comparison 2026 — Intrinsic Value Analysis

ONCO

Pharmaceutical Preparations

Onconetix, Inc.

Quality

4.5

out of 10

Value Trap

WARN

Price

$1.20

Last close

Models

9/13

Active

ONCY

Pharmaceutical Preparations

Oncolytics Biotech Inc.

Quality

3.4

out of 10

Value Trap

—

Price

$1.04

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ONCO Fair Value	ONCO Upside	ONCY Fair Value	ONCY Upside
Bayesian DCF	Intrinsic	$1.89	+57.1%	$0.24	-77.2%
Earnings Power Value	Intrinsic	$1.51	+138.5%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$0.16	-84.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ONCO vs ONCY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ONCO vs ONCY — Which Stock Is More Undervalued?

ONCO scores higher with a 4.5/10 quality rating vs ONCY's 3.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Onconetix, Inc. (ONCO) and Oncolytics Biotech Inc. (ONCY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ONCO currently trades at $1.20 with a QOC of 4.5/10, while ONCY trades at $1.04 with a QOC of 3.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).